IP Library Granted Patent US 8,357,778
Granted Patent B2
US 8,357,778 · App. 13/431,428 · Granted Jan 22, 2013

Polypeptide, an affinity chromatography material, and a method for separating and/or purifying immunoglobulin

Inventor: Satoshi Sato (Okayama, JP)
Assignee: Nomadic Bioscience Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,357,778
App. No.
13/431,428
Granted
Jan 22, 2013
Kind
B2
Abstract

A mutant of the polypeptide Protein A, wherein immunoglobulin binding properties can be altered by changing temperature under the conditions of pH 5-9, below 60° C. The use of the mutant Protein A include the use thereof as a ligand coupled to an affinity chromatography support for the purification of immunoglobulins by affinity chromatography, wherein the immunoglobulins is eluted by changing temperature and thereby the conformation of the mutant Protein A.

Claims (29)

1. A polypeptide, which is a mutant of the polypeptide of SEQ ID NO: 1 or SEQ ID NO: 2,

wherein immunoglobulin binding properties of the mutant can be altered by changing temperature under the conditions of pH 5-9, below 60° C.;

wherein at least Leu at position 19 and/or Leu at position 22 in the polypeptide of SEQ ID NO: 1 or SEQ ID NO: 2 is replaced with Ala or Gly; and

wherein Gly at position 29 in the polypeptide of SEQ ID NO: 1 is replaced with Ala.

2. The polypeptide according to claim 1 , wherein the Gibbs free energy for the polypeptide fulfills at least any one of the following formulas (I) to (III):

ΔΔ G X-BWT ≦−3.3 kcal/mol  (I)

ΔΔ G X-PWT ≦−4.2 kcal/mol  (II)

Δ G X-BGG ≦4.2 kcal/mol  (III)

(where ΔΔG X-BwT represents ΔG X −ΔG BWT , i.e., the difference between the Gibbs free energy for denaturation of the polypeptide, ΔG X , and the Gibbs free energy for denaturation of BWT (SEQ ID NO: 1), ΔG BWT , under the conditions of 25° C., 1 atmosphere, and pH 5.5,

ΔΔG X-PWT represents ΔG X −ΔG PWT , i.e., the difference between the Gibbs free energy for denaturation of the polypeptide, ΔG X , and the Gibbs free energy for denaturation of PWT (SEQ ID NO: 2), ΔG PWT , under the conditions of 25° C., 1 atmosphere, and pH 5.5, and

ΔΔG X-BGG represents ΔG X −ΔG BGG , i.e., the difference between the Gibbs free energy for denaturation of the polypeptide, ΔG X , and the Gibbs free energy for denaturation of the polypeptide of SEQ ID NO: 9, ΔG BGG , under the conditions of 25° C., 1 atmosphere, and pH 5.5).

3. The polypeptide according to claim 1 , wherein an immunoglobulin binding ratio thereof at 0° C. to 10° C. is 30% or more of an immunoglobulin binding ratio of the polypeptide of SEQ ID NO: 1 or SEQ ID NO: 2.

4. The polypeptide according to claim 1 , wherein the polypeptide is represented by any one of SEQ ID NOs: 9, 10 to 21, and 46.

5. The polypeptides according to claim 1 , wherein at least two or more of the polypeptides are included in one molecule of a larger polypeptide.

6. The polypeptide according to claim 1 , wherein the polypeptide is included in a molecule of a Protein A mutant.

7. The polypeptide according to claim 1 ,

wherein the polypeptide is included in an affinity chromatography material.

8. The polypeptide according to claim 7 , wherein the Gibbs free energy for the polypeptide fulfills at least any one of the following formulas (I) to (III):

ΔΔ G X-BWT ≦−3.3 kcal/mol  (I)

ΔΔ G X-PWT ≦−4.2 kcal/mol  (II)

ΔΔ G X-BGG ≦4.2 kcal/mol  (III)

(where ΔΔG X-BWT represents ΔG X −ΔG BWT , i.e., the difference between the Gibbs free energy for denaturation of the polypeptide, ΔG X , and the Gibbs free energy for denaturation of BWT (SEQ ID NO: 1), ΔG BWT , under the conditions of 25° C., 1 atmosphere, and pH 5.5,

ΔΔG X-PWT represents ΔG X −ΔG PWT , i.e., the difference between the Gibbs free energy for denaturation of the polypeptide, ΔG X , and the Gibbs free energy for denaturation of PWT (SEQ ID NO: 2), ΔG PWT , under the conditions of 25° C., 1 atmosphere, and pH 5.5, and

ΔΔG X-BGG represents ΔG X −ΔG BGG , i.e., the difference between the Gibbs free energy for denaturation of the polypeptide, ΔG X , and the Gibbs free energy for denaturation of the polypeptide of SEQ ID NO: 9, ΔG BGG , under the conditions of 25° C., 1 atmosphere, and pH 5.5).

9. The polypeptide according to claim 7 , wherein at least Leu at position 19 and/or Leu at position 22 in the polypeptide of SEQ ID NO: 1 or SEQ ID NO: 2 is replaced with Ala or Gly.

10. The polypeptide according to claim 7 , wherein an immunoglobulin binding ratio thereof at 0° C. to 10° C. is 30% or more of an immunoglobulin binding ratio of the polypeptide of SEQ ID NO: 1 or SEQ ID NO: 2.

11. The polypeptide according to claim 7 , wherein the polypeptide is represented by any one of SEQ ID NOs: 9, 10 to 21, and 46.

12. The polypeptides according to claim 7 , wherein at least two or more of the polypeptides are included in one molecule of a larger polypeptide.

13. The polypeptide according to claim 7 , wherein the polypeptide is included in a molecule of a Protein A mutant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2012
From: SATO, SATOSHI
To: NOMADIC BIOSCIENCE CO., LTD.
Reel/Frame 028033/0530 →
Priority Claims (1)
JP 2007-133778 · May 21, 2007 · national
Continuity (2)
Division 12600828
Related Publication 20120184711A1 · Jul 19, 2012